Citadel Investment Advisory, Inc. Enovis Corp Transaction History
Citadel Investment Advisory, Inc.
- $176 Million
- Q2 2024
A detailed history of Citadel Investment Advisory, Inc. transactions in Enovis Corp stock. As of the latest transaction made, Citadel Investment Advisory, Inc. holds 3,594 shares of ENOV stock, worth $172,871. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,594
Previous 4,755
24.42%
Holding current value
$172,871
Previous $296,000
45.27%
% of portfolio
0.09%
Previous 0.17%
Shares
8 transactions
Others Institutions Holding ENOV
# of Institutions
313Shares Held
58.3MCall Options Held
1.67MPut Options Held
403K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.59MShares$317 Million0.25% of portfolio
-
Black Rock Inc. New York, NY5.33MShares$257 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$235 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.19MShares$154 Million0.05% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH2.43MShares$117 Million0.62% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.6B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...